155 results
Page 4 of 8
6-K
EX-99.1
pj1yf2
14 Feb 20
Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2020
8:00am
6-K
EX-99.1
j3c8127ua6k6x99
13 Nov 19
Current report (foreign)
7:55am
6-K
EX-99.2
t1wxp7uu
13 Nov 19
Current report (foreign)
7:55am
6-K
EX-99.1
emz6ba
13 Nov 19
Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2020
7:55am
6-K
EX-99.1
jbxr2l0rrq1
9 Sep 19
Acasti Pharma Receives Funding from the Government of Canada to Expand Production Capacity
8:41am
6-K
EX-99.2
mro4sa7afn
14 Aug 19
Current report (foreign)
12:00am
6-K
EX-99.1
oroomvrs08agdem
14 Aug 19
Current report (foreign)
12:00am
F-3
qy92c93u
7 Aug 19
Shelf registration (foreign)
12:00am
POS AM
vu2fxh04
15 Jul 19
Prospectus update (post-effective amendment)
5:15pm
6-K
EX-99.1
0j8m2b3xvz
26 Jun 19
Acasti Pharma Provides Fiscal 2019 Year-End Business Update
8:06am
424B5
tplah20vw gpf
14 Feb 19
Prospectus supplement for primary offering
8:06am
6-K
EX-99.1
khlzilbh2fwibgiw
14 Feb 19
Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2019
8:05am
6-K
EX-99.1
s1aj6p
14 Feb 19
Current report (foreign)
7:55am
6-K
EX-99.2
b7modqtpbnt50
14 Feb 19
Current report (foreign)
7:55am
6-K
EX-99.1
pwl8l3whwb0 5k
14 Nov 18
Acasti Pharma Provides Business Update for Second Quarter of Fiscal 2019
8:05am
6-K
EX-99.2
cdf5yaz9ek4s5d3ss2
14 Nov 18
Current report (foreign)
7:00am
6-K
EX-99.1
ae1r6y t0
14 Nov 18
Current report (foreign)
7:00am
POS AM
31u16h 7ekp
12 Oct 18
Prospectus update (post-effective amendment)
5:05pm
424B5
pcdlew2o1de3819o1tp1
5 Oct 18
Prospectus supplement for primary offering
12:00am